ArticleJournal of thoracic disease2025
CT-based body composition and inflammatory nutritional biomarker nomogram for predicting early postoperative recurrence of non-small cell lung cancer: a multicenter study.
Article in Journal of thoracic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- CT-derived abdominal organ volumetrics for predicting recurrence-free and disease-free survival in resected non-small cell lung cancer: a multicenter retrospective cohort study.Translational lung cancer research · 2026Article
- CT-Based Nested Habitats Analysis for Early Recurrence Prediction and Risk Stratification in Hepatocellular Carcinoma: Development and Multicenter Validation Across Four Cohorts.Annals of surgical oncology · 2026Article
- Machine learning based on body composition radiomics for predicting early recurrence in colorectal cancer: a multicenter study.Frontiers in nutrition · 2026Article
- Article
- An Emergency-deployable Albumin-enhanced NLR Derived by Machine Learning Improves Risk Stratification in Lung Cancer: A Multicenter Cohort Study.In vivo (Athens, Greece)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The inflammatory-nutritional status of the human body holds considerable clinical significance for the prognosis of patients with malignant neoplasms. Meanwhile, the assessment of body composition (including adipose tissue and skeletal muscle) via computed tomography (CT) imaging also exhibits a significant correlation with the prognostic outcomes of patients with non-small cell lung cancer (NSCLC). However, the association between these two factors and early recurrence (ER) remains unclear. This study aims to evaluate the prognostic value of body composition and inflammatory nutritional biomarker (BCINB) in patients with NSCLC. A CT-based BCINB nomogram was developed to predict postoperative ER. Methods: A training cohort (251 patients, Jiangxi Cancer Hospital) and an external test cohort (104 patients, The Second Affiliated Hospital of Nanchang University) were analyzed. Body composition metrics and clinical-pathological parameters were evaluated. Least absolute shrinkage and selection operator (LASSO)-Cox regression identified BCINB components, and multivariate Cox regression determined ER predictors. Nomogram performance was validated via concordance index (C-index), calibration curves, time-dependent receiver operator characteristic curve (ROC) analysis, and decision curve analysis (DCA). Results: The BCINB score integrated systemic inflammation index (SII), systemic inflammatory response index (SIRI), albumin-globulin ratio (AGR), intramuscular adipose content (IMAC), intermuscular adipose tissue (IMAT) area, subcutaneous adipose tissue index (SATI), skeletal muscle density (SMD), and skeletal muscle index (SMI). It correlated with male sex, age >65 years, tumor size >3 cm, and stage III disease. BCINB independently predicted recurrence-free survival (RFS) [hazard ratio (HR): 13.853, 95% confidence interval (CI): 6.393-30.018]. The nomogram combining BCINB with clinicopathological variables yielded C-indices of 0.822 (95% CI: 0.78-0.864) and 0.806 (95% CI: 0.736-0.869) in training and test cohorts, respectively. Calibration curves confirmed accuracy in recurrence risk prediction. Compared to pathological Tumor-Node-Metastasis (pTNM) staging, the nomogram provided superior discrimination and clinical benefit for 1- and 2-year RFS across broader threshold probabilities. Conclusions: The BCINB score, integrating body composition, inflammation, and nutritional markers, is a robust prognostic tool for NSCLC. The nomogram enables precise postoperative ER risk stratification, outperforming conventional staging systems.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.